Ma Kuang Healthcare Holding Limited(TW:4139)
NT$35.60+0.30 (+0.85%)
TW:4139
Ma Kuang Healthcare Holding Limited financials statements
NT$35.60
At close:+0.30 (+0.85%)
Ma Kuang Healthcare Holding Limited (4139) Ratios
Ma Kuang Healthcare Holding Limited Ratios
TW:4139's free cash flow for Q2 2026 was NT$21.42M. For the 2026 fiscal year, TW:4139's free cash flow was decreased by NT$-3.49M and operating cash flow was NT$24.91M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.57 | 0.57 | 0.72 | 0.80 | 0.79 |
| Quick Ratio | 0.50 | 0.50 | 0.64 | 0.62 | 0.62 |
| Cash Ratio | 0.20 | 0.13 | 0.15 | 0.16 | 0.16 |
| Solvency Ratio | 0.15 | 0.25 | 0.14 | 0.12 | 0.22 |
| Operating Cash Flow Ratio | 0.39 | 0.59 | 0.32 | 0.33 | 0.45 |
| Short-Term Operating Cash Flow Coverage | 0.87 | 1.38 | 0.71 | 0.85 | 0.88 |
| Net Current Asset Value | NT$ -550.12M | NT$ -579.03M | NT$ -651.75M | NT$ -608.01M | NT$ -406.28M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.50 | 0.50 | 0.56 | 0.53 | 0.48 |
| Debt-to-Equity Ratio | 1.55 | 1.55 | 2.16 | 1.93 | 1.40 |
| Debt-to-Capital Ratio | 0.61 | 0.61 | 0.68 | 0.66 | 0.58 |
| Long-Term Debt-to-Capital Ratio | 0.24 | 0.22 | 0.37 | 0.40 | 0.22 |
| Financial Leverage Ratio | 3.12 | 3.08 | 3.84 | 3.61 | 2.89 |
| Debt Service Coverage Ratio | 0.52 | 0.89 | 0.61 | 0.71 | 0.71 |
| Interest Coverage Ratio | -0.70 | 0.22 | 0.57 | -0.24 | 3.61 |
| Debt to Market Cap | 0.39 | 0.27 | 0.35 | 0.28 | 0.21 |
| Interest Debt Per Share | 16.76 | 17.74 | 21.74 | 20.10 | 15.82 |
| Net Debt to EBITDA | 3.18 | 2.35 | 3.80 | 4.04 | 2.60 |
| Profitability Margins | |||||
| Gross Profit Margin | 11.29% | 13.31% | 14.10% | 15.18% | 18.05% |
| EBIT Margin | -2.46% | 4.88% | 1.22% | -0.33% | 8.24% |
| EBITDA Margin | 16.12% | 23.99% | 17.06% | 17.24% | 22.71% |
| Operating Profit Margin | -2.46% | 0.85% | 2.03% | -0.60% | 8.45% |
| Pretax Profit Margin | -6.21% | 0.95% | -2.33% | -2.85% | 5.90% |
| Net Profit Margin | -6.14% | 0.91% | -3.49% | -2.92% | 4.02% |
| Continuous Operations Profit Margin | -7.38% | -0.09% | -3.25% | -3.35% | 4.37% |
| Net Income Per EBT | 98.89% | 95.80% | 149.54% | 102.38% | 68.12% |
| EBT Per EBIT | 252.33% | 112.13% | -114.74% | 476.67% | 69.81% |
| Return on Assets (ROA) | -4.86% | 0.73% | -2.71% | -1.99% | 2.86% |
| Return on Equity (ROE) | -15.18% | 2.24% | -10.41% | -7.18% | 8.27% |
| Return on Capital Employed (ROCE) | -3.53% | 1.14% | 2.63% | -0.64% | 9.81% |
| Return on Invested Capital (ROIC) | -2.29% | -0.07% | 1.82% | -0.48% | 5.06% |
| Return on Tangible Assets | -5.39% | 0.81% | -2.99% | -2.20% | 3.04% |
| Earnings Yield | -6.31% | 0.75% | -2.87% | -1.72% | 2.09% |
| Efficiency Ratios | |||||
| Receivables Turnover | 7.72 | 7.84 | 5.47 | 5.45 | 5.06 |
| Payables Turnover | 99.04 | 154.20 | 46.70 | 16.76 | 32.83 |
| Inventory Turnover | 21.01 | 22.85 | 21.11 | 8.69 | 8.96 |
| Fixed Asset Turnover | 1.83 | 1.72 | 1.75 | 1.59 | 1.92 |
| Asset Turnover | 0.79 | 0.80 | 0.78 | 0.68 | 0.71 |
| Working Capital Turnover Ratio | -4.29 | -5.36 | -8.41 | -9.56 | -23.15 |
| Cash Conversion Cycle | 60.96 | 60.18 | 76.19 | 87.22 | 101.69 |
| Days of Sales Outstanding | 47.28 | 46.57 | 66.72 | 67.00 | 72.10 |
| Days of Inventory Outstanding | 17.37 | 15.98 | 17.29 | 41.99 | 40.72 |
| Days of Payables Outstanding | 3.69 | 2.37 | 7.82 | 21.77 | 11.12 |
| Operating Cycle | 64.65 | 62.54 | 84.01 | 109.00 | 112.81 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 5.52 | 7.99 | 4.69 | 4.46 | 5.45 |
| Free Cash Flow Per Share | 4.94 | 7.37 | 3.57 | 1.03 | 4.49 |
| Dividend Paid and CapEx Coverage Ratio | 9.52 | 12.76 | 4.16 | 1.30 | 2.13 |
| Capital Expenditure Coverage Ratio | 9.52 | 12.76 | 4.16 | 1.30 | 5.71 |
| Operating Cash Flow Coverage Ratio | 0.35 | 0.48 | 0.23 | 0.23 | 0.36 |
| Operating Cash Flow to Sales Ratio | 0.22 | 0.30 | 0.16 | 0.18 | 0.24 |
| Free Cash Flow Yield | 20.12% | 22.81% | 10.22% | 2.44% | 10.36% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -15.84 | 134.58 | -34.90 | -57.95 | 47.69 |
| Price-to-Sales (P/S) Ratio | 0.97 | 1.22 | 1.22 | 1.70 | 1.93 |
| Price-to-Book (P/B) Ratio | 2.40 | 3.00 | 3.63 | 4.18 | 3.97 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 4.97 | 4.38 | 9.79 | 40.93 | 9.66 |
| Price-to-Operating Cash Flow Ratio | 4.45 | 4.04 | 7.44 | 9.48 | 7.96 |
| Price-to-Earnings Growth (PEG) Ratio | 0.02 | -1.09 | -0.94 | 0.32 | -0.96 |
| Enterprise Value Multiple | 9.22 | 7.42 | 10.94 | 13.90 | 11.08 |
| Enterprise Value | 1.62B | 2.01B | 2.27B | 2.54B | 2.41B |
| EV to EBITDA | 9.22 | 7.42 | 10.94 | 13.90 | 11.08 |
| EV to Sales | 1.49 | 1.78 | 1.87 | 2.40 | 2.52 |
| EV to Free Cash Flow | 7.59 | 6.42 | 14.99 | 57.69 | 12.61 |
| EV to Operating Cash Flow | 6.79 | 5.91 | 11.39 | 13.36 | 10.40 |
| Tangible Book Value Per Share | 7.85 | 8.60 | 7.55 | 8.09 | 10.56 |
| Shareholders’ Equity Per Share | 10.21 | 10.78 | 9.61 | 10.11 | 10.94 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.19 | 1.09 | -0.39 | -0.18 | 0.26 |
| Revenue Per Share | 25.24 | 26.56 | 28.64 | 24.88 | 22.53 |
| Net Income Per Share | -1.55 | 0.24 | -1.00 | -0.73 | 0.90 |
| Tax Burden | 0.99 | 0.96 | 1.50 | 1.02 | 0.68 |
| Interest Burden | 2.52 | 0.19 | -1.91 | 8.71 | 0.72 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.13 | 0.12 | 0.11 | 0.12 | 0.13 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | -3.52 | 31.69 | -7.02 | -6.29 | 4.10 |
Currency in TWD
